Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancer
IntroductionThe immune system has proven to be a key player in the progression as well as containment of cancer with new treatment strategies based on immunotherapy targeting this interaction. Assessing immune function could reveal critical information about the immune response to therapeutic inter...
Main Authors: | Heidi Ryssel, Kristian Egebjerg, Susanne Dam Nielsen, Jens Lundgren, Mette Pøhl, Seppo W. Langer, Andreas Kjaer, Sisse Rye Ostrowski, Barbara Malene Fischer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1024224/full |
Similar Items
-
Improved induced innate immune response after cART initiation in people with HIV
by: Malene Hove-Skovsgaard, et al.
Published: (2022-08-01) -
Very Early Response Evaluation by PET/MR in Patients with Lung Cancer—Timing and Feasibility
by: Natasha Hemicke Langer, et al.
Published: (2019-03-01) -
Multiple Testing, Cut-Point Optimization, and Signs of Publication Bias in Prognostic FDG–PET Imaging Studies of Head and Neck and Lung Cancer: A Review and Meta-Analysis
by: Malene M. Clausen, et al.
Published: (2020-12-01) -
Correction: Christensen et al. Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. <i>Diagnostics</i> 2021, <i>11</i>, 279
by: Tine N. Christensen, et al.
Published: (2022-07-01) -
Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer
by: Tine N. Christensen, et al.
Published: (2021-02-01)